Sharps begins first commercial shipments; transitions to revenue-generating stage

Sharps Technology Inc.

Initiated shipments under three customer orders; first commercial revenue from $500K total purchase commitments.
Delivered initial $400K SoloGard order under $50M supply agreement with U.S. IV solutions leader.
Shipped $100K SecureGard order to Hungarian vaccine provider; first commercial order.
Began 200K unit shipment of 1mL syringes for Botox delivery pens to Swiss injectable therapies provider.
CEO Hayes says company now a commercial-stage, revenue-generating firm after R&D and manufacturing investments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.